Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-26 @ 3:14 PM
NCT ID:
NCT07330661
Eligibility Criteria:
Inclusion Criteria
* Age ≥ 18 years
* Any elective or emergency craniotomy, spinal, or other neurosurgical procedure
* Expected post-operative hospital stay ≥ 3 days
* Patient or legally authorized representative willing and able to give written informed consent
Exclusion Criteria
* Pre-operative ultrasound or imaging proven DVT or pulmonary embolism
* Known hereditary bleeding disorder (e.g., hemophilia) or platelet count \< 50 × 10⁹/L
* Chronic therapeutic anticoagulation (warfarin, DOAC, heparin) that cannot be safely stopped, or need for full-dose post-op anticoagulation
* Severe liver disease (Child-Pugh class C) or eGFR \< 30 mL/min/1.73 m²
* Life-limiting co-morbidity with expected survival \< 30 days
* Pregnancy or breastfeeding
* Current participation in another interventional VTE trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07330661
Study Brief:
Protocol Section:
NCT07330661